ATE99323T1 - Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung. - Google Patents

Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.

Info

Publication number
ATE99323T1
ATE99323T1 AT90902177T AT90902177T ATE99323T1 AT E99323 T1 ATE99323 T1 AT E99323T1 AT 90902177 T AT90902177 T AT 90902177T AT 90902177 T AT90902177 T AT 90902177T AT E99323 T1 ATE99323 T1 AT E99323T1
Authority
AT
Austria
Prior art keywords
solution
pct
recovering
epi protein
fermentation
Prior art date
Application number
AT90902177T
Other languages
English (en)
Inventor
Ole Nordfang
Soren Carlsen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE99323T1 publication Critical patent/ATE99323T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90902177T 1989-01-19 1990-01-18 Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung. ATE99323T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK412389A DK412389D0 (da) 1989-01-19 1989-01-19 Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning
PCT/DK1990/000016 WO1990008158A1 (en) 1989-01-19 1990-01-18 Method of recovering purified epi protein from a solution especially a fermentation solution

Publications (1)

Publication Number Publication Date
ATE99323T1 true ATE99323T1 (de) 1994-01-15

Family

ID=8130438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902177T ATE99323T1 (de) 1989-01-19 1990-01-18 Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.

Country Status (9)

Country Link
US (1) US5219993A (de)
EP (1) EP0454739B1 (de)
JP (1) JP2896605B2 (de)
AT (1) ATE99323T1 (de)
AU (1) AU5024490A (de)
DE (1) DE69005618T2 (de)
DK (2) DK412389D0 (de)
ES (1) ES2049021T3 (de)
WO (1) WO1990008158A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
HUP0501111A2 (en) 2001-10-15 2007-12-28 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721572A (en) * 1985-07-12 1988-01-26 Miles Laboratories, Inc. Purfication of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices

Also Published As

Publication number Publication date
US5219993A (en) 1993-06-15
DE69005618D1 (de) 1994-02-10
WO1990008158A1 (en) 1990-07-26
AU5024490A (en) 1990-08-13
ES2049021T3 (es) 1994-04-01
DK0454739T3 (da) 1994-04-25
JPH05505385A (ja) 1993-08-12
JP2896605B2 (ja) 1999-05-31
DE69005618T2 (de) 1994-04-28
EP0454739B1 (de) 1993-12-29
EP0454739A1 (de) 1991-11-06
DK412389D0 (da) 1989-01-19

Similar Documents

Publication Publication Date Title
DE69003093D1 (de) Verfahren zur herstellung von alpha-beta-ungesättigten ketonen.
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
DE68903417D1 (de) Verfahren zur herstellung von olefinen aus erdgas.
DE69110663D1 (de) Verfahren zur herstellung eines enzymhydrolysates.
DE69011859D1 (de) Verwendung von sigma-rezeptor-liganden zur herstellung eines anxiolytikums.
DE3675385D1 (de) Verfahren zur herstellung von linearen alpha-olefinen.
ATE132904T1 (de) Verfahren zur herstellung von trehalulose und isomaltulose
DE58903791D1 (de) Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69026695D1 (de) Verfahren zur herstellung von hochfestem rostfreien bandstahl mit ausgezeichneten federeigenschaften
DE69719497D1 (de) Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
DE3784761D1 (de) Verfahren zur herstellung eines mesfets.
DE3585084D1 (de) Verfahren zur reinigung eines proteins.
ATE99323T1 (de) Verfahren zur wiedergewinnung eines gereinigten epi-proteins aus einer loesung, insbesondere einer gaerungsloesung.
ATE65407T1 (de) Verfahren zur herbeifuehrung der ovulation.
DE68903697D1 (de) Verfahren zur herstellung von oligomeren eines alpha-olefins.
DE69432706D1 (de) Verfahren zur reinigung von "basic" fibroblasten wachstumsfaktor
DE69013621D1 (de) Verfahren zur Herstellung von tertiärem Amino-Alkohol.
ATE143371T1 (de) Verfahren zur proteinreinigung
DE3882154D1 (de) Verfahren zur herstellung des pres 1/s2/s-hepatitis-b-antigens aus hefe.
DE59309002D1 (de) Verfahren zur Herstellung von 6-Chlor-(6H)-dibenz-(c,e)(1,2)-oxaphosphorin
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
AT387768B (de) Verfahren zur duengung von weinkulturen durch anwendung eines duengers aus pilzbiomasse
KR910011898A (ko) 데스(64,65)-프로인슐린의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee